Rowlandmiller & Partners’s Humacyte HUMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$103K	Buy	+49,300	New	+$103K	0.02%	184
2025 Q1	–	Sell	-31,500	Closed	-$159K	–	188
2024 Q4	$159K	Buy	+31,500	New	+$159K	0.03%	152